Target intelligence / Profile preview

Cell wall synthesis proteins

Molecular classification
Enzyme, Other (for structural or scaffolding proteins involved in cell wall synthesis complexes)
01

Overview

Cell wall synthesis proteins in bacteria (chiefly penicillin-binding proteins and associated enzymes such as transglycosylases, transpeptidases, and the Mur family) synthesize and remodel the peptidoglycan layer, which is critical for maintaining cell structure and integrity, resistance to osmotic lysis, and supporting cell division. These proteins are the principal targets of several classes of antibiotics, notably β-lactams and glycopeptides. However, the term "cell wall synthesis proteins" is a non-specific grouping; for drug discovery or biomarker purposes, identification of the particular enzyme (e.g., PBP2, PBP3, MurA) is necessary. The term is too broad for most structured target databases and should be replaced with the specific protein (such as "Penicillin-binding protein 2a (PBP2a)") for actionable and unambiguous use in research and drug development.

Other names
cell wall synthesis enzymesbacterial cell wall biosynthesis proteinsPBPs (for penicillin-binding proteins)transglycosylasestranspeptidasesMur enzymes
02

Mechanism of action

Inhibition of transpeptidase/cross-linking activity (β-lactams) Inhibition of transglycosylase (glycopeptides) Blockade of precursor synthesis (fosfomycin, cycloserine)

03

Biological functions

Cell wall biosynthesisMaintenance of cell shapeCell divisionResistance to osmotic stress
04

Disease associations

Infection (essential for bacterial viability, targeted by antibiotics)
05

Safety considerations

Limited to pathogens (cell wall synthesis is not present in eukaryotic host cells, so off-target effects are rare)Antibiotic resistance (especially via PBP mutation or acquisition, β-lactamases, altered cell wall precursors)
06

Interacting drugs

β-lactam antibiotics (penicillins, cephalosporins, carbapenems, monobactams)

4 more in the full profile.

07

Biomarkers

Mutations in PBP genes (e.g., mecA in MRSA encoding PBP2a) as markers of resistancePeptidoglycan composition or abundance (for efficacy monitoring or resistance)

Beyond the preview

Go deeper on Cell wall synthesis proteins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cell wall synthesis proteins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call